Pharma Focus America

Pharma Focus America Welcome to Pharma focus America! We bring you the latest insights, innovations, and news from the world of pharmaceuticals. Ltd..

Join our community to stay updated and engage with industry experts! About Pharma Focus America:
Pharma Focus Aerica is a half yearly publication from Ochre Media Pvt. It is the leading pharma title in print and digital versions serving the information needs of key executives from the world’s leading pharmaceutical companies. Pharma Focus America covers important issues and trends shaping the future of the pharma industry across America and rest of the world. Pharma Focus America offers . . .
• Dedicated, reliable and accurate coverage of the industry’s progress and
• Incisive analysis to help its readers make informed decisions to stay ahead of the competition. The magazine provides cutting-edge and futuristic content on the pharma industry. The issues are broadly categorized into various sections:
• Strategy
• Research and Development
• Manufacturing
• Clinical Trials
• Information Technology

The one-stop pharma destination www.pharmafocusamerica.com features complete content from the Pharma Focus America magazine. Also find the latest pharma news, press releases, pharma industry reports, interviews, trends and pharma events updated on a daily basis. The magazine is supplemented by the monthly e-Newsletter: Verticaltalk Pharma. The readership
The magazine’s readership includes the top C-level executives, senior industry executives, and key decision makers from the pharma industry in charge of spending. With a special focus on America, Pharma Focus America reaches out to the key industry leaders across America, Europe and the Asia.

Clinical research is evolving beyond traditional trial models.In the latest issue of 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐦𝐞𝐫𝐢𝐜𝐚, Sowmya Kaur, ...
05/03/2026

Clinical research is evolving beyond traditional trial models.

In the latest issue of 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐦𝐞𝐫𝐢𝐜𝐚, Sowmya Kaur, Executive Vice President at Navitas Life Sciences, explains how Real-World Evidence (RWE), patient registries, and decentralized clinical trials are shaping the future of drug development.

By integrating real-world data from electronic health records, wearable devices, and registries, pharmaceutical companies can design smarter trials, recruit more diverse patient populations, and generate insights that better reflect real clinical practice.

Regulatory authorities like the U.S. Food and Drug Administration and European Medicines Agency are increasingly supporting these models, making RWE a critical component of modern clinical research.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐚𝐫𝐭𝐢𝐜𝐥𝐞: https://www.pharmafocusamerica.com/magazine

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐞𝐁𝐨𝐨𝐤 𝐧𝐨𝐰:
https://www.pharmafocusamerica.com/magazine

Single-arm trials are gaining momentum in European oncology approvals.In 𝐈𝐬𝐬𝐮𝐞 𝟎𝟔 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐦𝐞𝐫𝐢𝐜𝐚, Vikram Gosain...
04/03/2026

Single-arm trials are gaining momentum in European oncology approvals.

In 𝐈𝐬𝐬𝐮𝐞 𝟎𝟔 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐦𝐞𝐫𝐢𝐜𝐚, Vikram Gosain (Partner, Inizio) and Andris Ortmanis (Senior Director, Inizio) analyze EMA’s growing acceptance of SATs—and how the new EU HTA framework impacts launch strategy.

For oncology innovators, strong design and integrated evidence planning are essential.

𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞 𝐢𝐧 𝐈𝐬𝐬𝐮𝐞 𝟎𝟔: https://www.pharmafocusamerica.com/clinical-trials/why-single-arm-trials-are-gaining-ground-in-oncology-approvals

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐦𝐚𝐠𝐚𝐳𝐢𝐧𝐞: https://www.pharmafocusamerica.com/magazine

PROCOS S.P.A. (CBC Group) has reached a major milestone in its growth journey with the completion and regulatory approva...
04/03/2026

PROCOS S.P.A. (CBC Group) has reached a major milestone in its growth journey with the completion and regulatory approval of R11, a new state-of-the-art multipurpose GMP manufacturing facility. www.procos.it

With an investment exceeding €60 million, R11 significantly expands our capacity and flexibility in small-molecule API manufacturing, supporting clinical and commercial supply while meeting the highest quality and sustainability standards.

Designed to adapt to evolving market and regulatory needs, R11 reinforces PROCOS’ long-term strategy focused on innovation, operational excellence, and responsible growth. This achievement further strengthens our position as a trusted CDMO partner worldwide. www.procos.it

The US pharmaceutical industry is evolving—and so is 𝐁𝟐𝐁 𝐥𝐞𝐚𝐝 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧.Instead of casting a wide net, leading pharma c...
03/03/2026

The US pharmaceutical industry is evolving—and so is 𝐁𝟐𝐁 𝐥𝐞𝐚𝐝 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧.

Instead of casting a wide net, leading pharma companies are focusing on 𝐀𝐜𝐜𝐨𝐮𝐧𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 (𝐀𝐁𝐌) to build stronger relationships with high-value biotech firms, CDMOs, CROs, and hospital networks.

𝐖𝐡𝐲 𝐀𝐁𝐌 𝐰𝐨𝐫𝐤𝐬 𝐢𝐧 𝐩𝐡𝐚𝐫𝐦𝐚:
• Personalized engagement with decision-makers
• Better alignment between sales and marketing
• Higher-quality pharma digital leads
• Stronger pipeline growth

In 2026, precision matters more than volume. The companies that prioritize strategic accounts are seeing better ROI and long-term partnerships.

𝐀𝐫𝐞 𝐲𝐨𝐮 𝐚𝐝𝐚𝐩𝐭𝐢𝐧𝐠 𝐲𝐨𝐮𝐫 𝐁𝟐𝐁 𝐩𝐡𝐚𝐫𝐦𝐚 𝐦𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐲?

𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞: https://www.pharmafocusamerica.com/articles/abm-pharma-tactics-us-b2b-lead-gen

𝐏𝐑𝐎𝐂𝐎𝐒 has reached a major milestone in its growth journey with the completion and regulatory approval of R11, a new sta...
02/03/2026

𝐏𝐑𝐎𝐂𝐎𝐒 has reached a major milestone in its growth journey with the completion and regulatory approval of R11, a new state-of-the-art multipurpose GMP manufacturing facility.

With an investment exceeding €60 million, R11 significantly expands our capacity and flexibility in small-molecule API manufacturing, supporting clinical and commercial supply while meeting the highest quality and sustainability standards.

Designed to adapt to evolving market and regulatory needs, R11 reinforces PROCOS’ long-term strategy focused on innovation, operational excellence and responsible growth. This achievement further strengthens our position as a trusted CDMO partner worldwide.

www.procos.it

Clinical trials succeed when participants stay engaged—but decentralized tracking often leads to delays, higher costs, a...
27/02/2026

Clinical trials succeed when participants stay engaged—but decentralized tracking often leads to delays, higher costs, and missed enrollment goals. Centralized technology platforms give sponsors and sites real-time visibility, proactive risk management, and better support for participants.

Written by Kari Lotsberg, Seth Halvorson, and Tyler Bye, this piece from Pharma Focus America, Issue 06, shares actionable strategies to improve trial recruitment and retention.

https://www.pharmafocusamerica.com/clinical-trials/enabling-successful-trial-recruitment-through-centralized

Download the e-book now and learn how technology can enhance your clinical trial outcomes: https://www.pharmafocusamerica.com/magazine

Small patient populations. High variability. Limited statistical power.Rare disease drug development challenges traditio...
26/02/2026

Small patient populations. High variability. Limited statistical power.

Rare disease drug development challenges traditional hypothesis testing standards.

In Issue 06 of Pharma Focus America, Shein-Chung Chow, PhD, Duke University School of Medicine, explains how a confidence interval approach could improve feasibility and reproducibility in clinical investigations.

Read the article: https://www.pharmafocusamerica.com/research-development/a-controversial-issue-in-clinical-investigation

Download the e-book today: https://www.pharmafocusamerica.com/research-development/a-controversial-issue-in-clinical-investigation

Pharma is at an AI tipping point. Billions are being invested—but most companies are still struggling to generate real r...
25/02/2026

Pharma is at an AI tipping point. Billions are being invested—but most companies are still struggling to generate real returns.

In Issue 06 of 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐦𝐞𝐫𝐢𝐜𝐚, Lavinia Woodward, Senior Product Developer at Beacon, explains why success depends on building unified AI-powered R&D platforms—not running disconnected pilots.

Leaders like Novartis and GSK are proving that platform thinking eliminates data silos and accelerates innovation.

Recursion Pharmaceuticals has already cut development timelines dramatically through its AI-native operating system.

The competitive divide is widening. Organizations that act now will shape the future of drug development.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐢𝐧 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐦𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐢𝐬𝐬𝐮𝐞: https://www.pharmafocusamerica.com/research-development/ai-in-rd-platforms-platform-or-perish

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐞-𝐛𝐨𝐨𝐤 𝐭𝐨𝐝𝐚𝐲: https://www.pharmafocusamerica.com/magazine

The pharmaceutical industry is evolving fast—and leaders need more than headlines.𝐏𝐡𝐚𝐫𝐦𝐚 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐦𝐚𝐠𝐚𝐳𝐢𝐧𝐞𝐬 now deliver r...
24/02/2026

The pharmaceutical industry is evolving fast—and leaders need more than headlines.

𝐏𝐡𝐚𝐫𝐦𝐚 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐦𝐚𝐠𝐚𝐳𝐢𝐧𝐞𝐬 now deliver real-time regulatory intelligence, biopharma innovation updates, sustainability strategies, and AI-powered drug development insights—all in one place.

For executives, researchers, and biotech innovators, trusted B2B pharma content helps reduce risk, guide investments, and strengthen competitive strategy.

Ready to stay informed and future-focused?

👉 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐚𝐧𝐝 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐩𝐡𝐚𝐫𝐦𝐚 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐭𝐨𝐝𝐚𝐲: https://www.pharmafocusamerica.com/articles/pharma-digital-magazines-industry-leaders

Biosimilars are becoming the “pressure valve” for rising drug costs in the US—but is the market truly ready for the next...
20/02/2026

Biosimilars are becoming the “pressure valve” for rising drug costs in the US—but is the market truly ready for the next decade?

In Pharma Focus America—Issue 06, 𝐓𝐡𝐨𝐦𝐚𝐬 𝐍𝐞𝐰𝐜𝐨𝐦𝐞𝐫 (𝐕𝐏 & 𝐇𝐞𝐚𝐝 𝐨𝐟 𝐔𝐒 𝐂𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬, 𝐒𝐚𝐦𝐬𝐮𝐧𝐠 𝐁𝐢𝐨𝐞𝐩𝐢𝐬) examines the current trends and commercial challenges shaping the US biosimilar market.

✔ 53% average ASP reduction within five years
✔ 52% average market share after five years
✔ Growing private-label strategies
✔ IRA pricing pressures reshaping launch dynamics

Yet pharmacy-benefit biosimilars still struggle for meaningful uptake. Policy shifts, formulary positioning, and reimbursement models will determine whether biosimilars can sustain innovation while delivering affordability.

The future of biologics depends on building confidence across payers, providers, and patients.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐦𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐢𝐬𝐬𝐮𝐞: https://www.pharmafocusamerica.com/strategy/us-biosimilar-market-current-trends-challenges

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐞-𝐛𝐨𝐨𝐤 𝐭𝐨𝐝𝐚𝐲 𝐚𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.pharmafocusamerica.com/magazine

Attention pharma leaders and researchers! Stay informed with the latest in pharma—from cutting-edge RESEARCH INSIGHTS an...
19/02/2026

Attention pharma leaders and researchers! Stay informed with the latest in pharma—from cutting-edge RESEARCH INSIGHTS and TECHNO TRENDS to INDUSTRIAL PROJECTS and exclusive INTERVIEWS. Pharma Focus America’s newsletter is designed to keep you connected to everything that matters in the industry.

https://industry.pharmafocusamerica.com/e-newsletters/1771404199-Pharma-Focus-America-Feb-26.html

𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐭𝐨𝐝𝐚𝐲 𝐚𝐧𝐝 𝐛𝐞 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧:
https://www.pharmafocusamerica.com/e-newsletter-subscribe

𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 helps solution providers connect directly with America’s top pharmaceutical and biopharma decision-...
17/02/2026

𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 helps solution providers connect directly with America’s top pharmaceutical and biopharma decision-makers—the leaders shaping R&D, manufacturing, clinical innovation, and digital transformation.

With executive-level readership and measurable ROI-driven campaigns, your brand gains more than impressions—it gains influence.

Ready to strengthen your presence in the American pharma market?

https://www.pharmafocusamerica.com/articles/advertise-with-pharma-focus-america

𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐦𝐞𝐫𝐢𝐜𝐚: https://www.pharmafocusamerica.com/advertise

Address

111, 112 First Floor, Block 2, White House
Hyderabad
500016

Website

Alerts

Be the first to know and let us send you an email when Pharma Focus America posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category